Published on
July 19, 2015
- 10:00 GMT
Herpes Vaccine in Development Fails During Clinical Trials; The CBCD Reviews a Report
“Vical Inc. said its genital herpes vaccine didn’t meet the primary endpoint in a Phase 1/Phase 2 clinical trial.” (1) ROCHESTER, NEW YORK, UNITED STATES OF AMERICA, July 15, 2015 /EINPresswire.com/ -- “Infected with a herpes virus? The CBCD …
Distribution channels:
Consumer Goods, Culture, Society & Lifestyle
...
